May 01, 2011 »
Print Issue: May 01, 2011
Some of the health risks that halted the Women’s Health Initiative (WHI) trial have dissipated as more time has passed, according to a recent analysis.
At what level is creatinine considered a contraindication to placing a patient on an ACE inhibitor or angiotensin II receptor blocker?
Is sertraline effective as an off-label treatment for irritable bowel syndrome?
Navigating social media is especially tough for young professionals. Did a nursing student cross the line?
Clinician seeks advice regarding a patient that refuses chemotherapy for multiple myeloma because of concerns that her hair will fall out.
Do I really need to worry about vials with latex tops or BP cuffs with latex bladders? Can’t rash be treated symptomatically, or is escalation to anaphylaxis a major concern?
Clinicians asks advice for appropriate vaccine procedure for health care workers who received childhood vaccines, but cannot supply documentation and no longer have immunity to measles, mumps or rubella.
Clinician shares an unexpected dermatologic use for fluticasone.
If a woman has taken OTC phenazopyridine, and urine dipstick results are skewed, is it appropriate to treat empirically with antibiotics based on history and exam findings?
What percentage of women on oral contraceptives (OCs) develops gallstones or cholecystitis? Also, if OCs are a risk for blood clots, why are they commonly prescribed to those who smoke?
Next post in Consultations